(Q46122543)

English

Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology

scientific article published on 18 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology (English)

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

malignant pleural mesothelioma

1 reference

based on heuristic

inferred from title

author name string

Pier Aldo Canessa

1

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

Maria Cristiana Franceschini

2

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

Paola Ferro

3

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

Enrico Battolla

4

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

Paolo Dessanti

5

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

Carmen Manta

6

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

Massimiliano Sivori

7

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

Riccardo Pezzi

8

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

Vincenzo Fontana

9

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

Franco Fedeli

10

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

Maria Pia Pistillo

11

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

Silvio Roncella

12

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

publication date

18 December 2012

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

Cancer Investigation

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

31

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

1

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

43-50

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

The management of malignant pleural mesothelioma; single centre experience in 10 years

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Malignant mesothelioma in south east England: clinicopathological experience of 272 cases

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Biomarkers for malignant pleural mesothelioma: current status

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Malignant pleural effusion, current and evolving approaches for its diagnosis and management

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma.

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Malignant pleural mesothelioma: an update on biomarkers and treatment

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Diagnosis and origin determination of malignant pleural effusions through the use of the breast cancer marker human mammaglobin.

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Value of mesothelin immunostaining in the diagnosis of mesothelioma.

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

MESOMARK: a potential test for malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden.

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Diagnostic value of soluble mesothelin-related peptides for malignant mesothelioma: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancer

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions.

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

The diagnostic odds ratio: a single indicator of test performance

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Mesothelin-family proteins and diagnosis of mesothelioma

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Soluble Mesothelin-Related Peptide and Osteopontin As Markers of Response in Malignant Mesothelioma

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Soluble Mesothelin–related Peptides in the Diagnosis of Malignant Pleural Mesothelioma

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Incidence of pleural mesothelioma in Liguria Region, Italy (1996–2002)

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2012.749265

21 January 2018

Identifiers

10.3109/07357907.2012.749265

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/23249166

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46122543&oldid=2093448191"